Show Summary Details
Page of

Index 

Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 September 2020

A
A-a (alveolar-to-arterial) gradient, [link]
ABCD2 score, [link][link]
abciximab, [link]
abdominal pain
approach to patient with, [link][link]
causes of, [link]
in DKA evaluation, [link]
recommendations for managing patients with, [link]
ablation, for atrial fibrillation, [link]
ABPA (allergic bronchopulmonary aspergillosis), [link]
absence seizures, [link][link]
absolute polycythemia, [link][link]
absorption abnormalities, [link]
AC (assist control), [link]
ACC/AHA (American College of Cardiology/American Heart Association) Staging System, [link]
ACD (anemia of chronic disease), [link]
ACE (angiotensin-converting enzyme) inhibitors. See [link]
acetaminophen
acute liver failure due to, [link], [link], [link]
in fever management, [link]
overdose, [link][link]
for pain treatment in dying patients, [link]
acid-base disorders
described, [link]
differential diagnosis of
metabolic acidosis, [link][link]
metabolic alkalosis, [link][link]
evaluation of, steps in, [link][link]
acidemia, [link][link]
acid-fast bacillus stain, [link]
acidosis
alcoholic ketoacidosis, [link], [link][link]
anion gap, [link]
diabetic ketoacidosis, [link], [link][link]
dialysis in management of, [link]
due to inorganic acids, [link]
lactic, [link]
metabolic
acute dyspnea and, [link]
acute liver failure and, [link]
differential diagnosis of, [link], [link][link]
evaluation of, [link][link]
hyperkalemia and, [link]
nonanion gap, [link]
post-anion gap, [link]
renal tubular, [link], [link]
respiratory, [link], [link], [link]
acidosis-induced hyperkalemia, [link]
ACOS (asthma-COPD overlap syndrome), [link]
acquired clotting disorders, [link][link]
acquired clubbing, [link]
acquired platelet dysfunction, [link][link]
acquired storage pool disease, [link]
ACS. See [link]
ACTH (cosyntropin) stimulation test, [link]
Actinomyces, [link]
activated charcoal, [link][link], [link], [link]
acute adrenal insufficiency, [link], [link]
acute axonal polyneuropathies, [link]
acute bacterial endocarditis, [link]
acute bacterial meningitis, [link], [link], [link]
acute coronary syndrome (ACS)
approach to patient with, [link][link]
clinical manifestations of, [link]
complications of, [link][link]
diagnosis of, [link][link]
overview, [link]
pathophysiology of, [link]
post-hospitalization and long-term management of, [link][link]
acute demyelinating polyneuropathies, [link]
acute dialysis, [link]
acute diarrhea
approach to patient with, [link][link]
classification of, [link]
defined, [link]
in hospitalized patients, common causes of, [link]
treatment of, [link]
acute dyspnea
approach to patient with, [link]
causes of, [link]
defined, [link]
treatment of, [link]
acute endocarditis, [link]
acute glomerulonephritis, [link], [link], [link], [link]
acute heart failure (HF), [link][link]
acute hepatitis, [link]
acute inflammatory demyelinating polyradiculoneuropathy (AIDP), [link][link]
acute intermittent porphyria, [link]
acute interstitial nephritis, [link], [link]
acute kidney injury (AKI)
approach to patient with, [link][link]
causes of, [link][link]
clinical manifestations of, [link]
defined, [link]
epidemiology of, [link]
treatment of, [link][link]
acute leukemia
approach to patient with, [link][link]
classification of, [link][link]
clinical manifestations of, [link][link]
complications associated with, [link][link]
described, [link]
epidemiology of, [link]
MDS and, [link]
risk factors for, [link]
treatment of, [link][link]
acute liver failure
causes of, [link][link]
clinical manifestations of, [link][link]
defined, [link]
treatment of, [link]
acute lymphoblastic leukemia (ALL)
approach to patient with, [link][link]
clinical manifestations of, [link][link]
complications associated with, [link][link]
described, [link][link]
epidemiology of, [link]
risk factors for, [link]
treatment of, [link][link]
acute mitral regurgitation, from ACS, [link][link]
acute myeloid leukemia (AML)
approach to patient with, [link][link]
clinical manifestations of, [link][link]
complications associated with, [link][link]
described, [link]
epidemiology of, [link]
risk factors for, [link]
treatment of, [link][link]
acute pancreatitis
approach to patient with, [link]
causes of, [link][link]
clinical manifestations of, [link]
complications of, [link]
defined, [link]
treatment of, [link][link]
acute respiratory distress syndrome (ARDS), [link]
acute rheumatic fever
defined, [link]
described, [link]
diagnosis of, [link][link]
epidemiology of, [link]
polyarthritis due to, [link]
treatment of, [link]
acute splenomegaly, [link][link]
acute tubular necrosis (ATN), [link], [link][link], [link]
acyclovir
HIV-related viral esophagitis, [link]
in meningitis management, [link]
Addison’s disease
causes of, [link]
clinical manifestations of, [link]
eosinophilia due to, [link]
hypercalcemia due to, [link]
ADE. See [link]
adenosine
in angina evaluation, [link]
for narrow, regular tachycardia, [link]
for VT, [link]
ADH. See [link]
administration errors, [link]
adrenal crisis, [link], [link]
adrenal disease, hypercalcemia due to, [link]
adrenal insufficiency
approach to patient with, [link]
causes of, [link]
clinical manifestations of, [link][link]
definitions, [link]
primary, [link], [link], [link]
secondary, [link], [link][link], [link]
tertiary, [link], [link]
treatment of, [link][link]
adult-onset Still’s disease (AOSD), [link], [link][link]
adverse drug event (ADE)
definition, [link]
incidence of, [link]
prevention of
administration errors, [link][link]
anticipation of complications, [link]
dispensing errors, [link]
medication information, [link][link]
ordering, [link][link]
adverse events, defined, [link]
AEDs (antiepileptic drugs), [link][link]
aerobic gram-negative rods, [link]
AIDP (acute inflammatory demyelinating polyradiculoneuropathy), [link][link]
AIDS-associated enteropathy, [link]
AIDS cholangiopathy, [link]
AIHA (autoimmune hemolytic anemia), [link], [link]
airflow limitation, [link]
AKA (alcoholic ketoacidosis), [link], [link][link]
AKI. See [link]
albuterol, in hyperkalemia management, [link]
alcohol abuse
acute pancreatitis due to, [link]
alcohol intoxication, [link][link]
alcohol withdrawal, [link][link]
alcoholic hepatitis, [link][link]
alcoholic ketoacidosis (AKA), [link], [link][link]
alcoholic liver disease
approach to patient with, [link][link]
clinical manifestations of, [link]
described, [link]
treatment of, [link][link]
alcoholism
approach to patient with, [link]
detection of, [link]
ESLD due to, [link]
macrocytic anemia due to, [link]
alcohol use, hospitalization and, [link]
aldosterone antagonists
in ACS management, [link]
in chronic HFrEF management, [link]
alkalemia, [link], [link]
alkali ingestion, hypercalcemia due to, [link]
alkalosis
metabolic, [link], [link], [link][link]
respiratory, [link], [link], [link][link]
alkylating agents
in ET management, [link]
in PV management, [link]
ALL. See [link]
allergic bronchopulmonary aspergillosis (ABPA), [link]
allergic disorders, eosinophilia due to, [link]
allergic interstitial nephritis, [link]
allodynia, [link]
allogeneic bone marrow transplantation
in AML management, [link]
in CML management, [link]
complications of, [link]
in MDS management, [link]
in PMF management, [link]
alopecia areata, [link][link]
altered mental status
acute dyspnea evaluation, [link]
acute liver failure and, [link][link]
approach to patient with, [link][link]
causes of, [link]
definitions, [link]
from meningitis, [link]
alveolar gas equation, [link]
alveolar infiltrates, [link]
alveolar proteinosis, [link]
alveolar-to-arterial (A-a) gradient, [link]
amebiasis, FUO due to, [link]
American College of Cardiology/American Heart Association (ACC/AHA) Staging System, [link]
amiodarone
for atrial fibrillation, [link], [link]
for VT, [link]
AML. See [link]
amlodipine, in angina management, [link]
amoxicillin, in cystitis management, [link]
amphetamine overdose, [link]
ampicillin, in meningitis management, [link]
amyloid, nephrotic syndrome due to, [link]
amyloidosis, in multiple myeloma evaluation, [link]
anaerobe(s), [link]
anagrelide
in ET management, [link]
in thrombocytosis management, [link]
analgesic(s), nonopioid, in pain management, [link]
anaphylactic shock, [link]
anasarca, [link]
anatomic renal tubular defects, [link]
anemia of chronic disease (ACD), [link]
anemia(s)
acute dyspnea and, [link]
acute leukemia and, [link]
aplastic, [link], [link]
classification, [link]
clinical manifestations of, [link]
defined, [link]
iron deficiency, [link], [link], [link], [link]
macrocytic, [link]
megaloblastic, [link]
microcytic, [link][link]
in multiple myeloma evaluation, [link]
normocytic, [link][link]
pancytopenia and, [link], [link]
sideroblastic, [link]
anesthesia/anesthetics, [link], [link]
angina
anginal equivalents, [link]
approach to patient with, [link][link]
atherosclerosis, risk factors for, [link]
coronary artery disease, clinical manifestations of, [link][link]
defined, [link]
stable, [link]
stress tests, [link][link]
treatment of, [link][link]
unstable, [link][link]
angiodysplasia, [link]
angiography
coronary
in ACS management, [link]
cardiac catheterization with, [link]
CT
in angina evaluation, [link]
in pulmonary embolism evaluation, [link], [link]
in stroke evaluation, [link]
MRA, in stroke evaluation, [link]
pulmonary, in pulmonary embolism evaluation, [link]
angiotensin-converting enzyme (ACE) inhibitors
in ACS management, [link][link]
in angina management, [link]
in chronic HFrEF management, [link]
hyperkalemia from, [link]
in hypertension management, [link]
in polycythemia management, [link]
angiotensin receptor blockers (ARBs)
in ACS management, [link][link]
in angina management, [link]
in chronic HFrEF management, [link]
in hypertension management, [link]
angiotensin receptor-neprilysin inhibitor (ARNI), in chronic HFrEF management, [link]
animal bites, [link], [link][link]
anion gap
calculating, [link][link]
in multiple myeloma evaluation, [link]
anion gap acidosis, [link], [link]
ankle-foot orthotics, [link]
Ann Arbor classification system, [link], [link]
antacid medications, [link]
anterior wall myocardial infarction, [link]
antiarrhythmic therapy, for atrial fibrillation, [link]
antibiotic(s)
in acute diarrhea management, [link]
in acute rheumatic fever management, [link]
in cystitis management, [link]
in fever management, [link][link]
in obstructive lung disease management, [link]
in pancytopenia management, [link]
antibody tests, [link]
anticholinergics
for dyspnea, [link]
for nausea and vomiting, [link]
toxicity of, [link]
anticoagulant(s)
in ACS management, [link]
for atrial fibrillation, [link][link]
for hypercoagulable states, [link][link]
in PNH management, [link]
in pulmonary embolism management, [link]
anticonvulsant(s), in pain management, [link]
antidepressant(s)
for anxiety in dying patients, [link]
for depression in dying patients, [link]
TCAs
in neuropathic pain management, [link]
overdose, [link][link]
for pain treatment in dying patients, [link]
antidiuretic hormone (ADH)
described, [link]
SIADH, [link]
antidotes, [link]
antidromic conduction, [link]
antiepileptic drugs (AEDs), [link][link]
anti-GBM-associated diseases, [link]
antihistamine(s)
for nausea and vomiting, [link]
in pruritus management, [link]
antimicrobial therapy
described, [link]
surgical debridement with, for necrotizing soft tissue infection, [link]
antimotility agents, in acute diarrhea management, [link]
antiphospholipid antibodies, [link], [link]
antiphospholipid antibody syndrome, [link], [link][link]
antiplatelet therapy, in ACS management, [link]
antipsychotic(s), for anxiety in dying patients, [link]
antipyretic therapy, in fever management, [link]
antithrombin deficiency, [link][link]
antithymocyte globulin, in aplastic anemia management, [link]
anxiety
acute dyspnea from, [link]
in dying patients, management of, [link]
aortic coarctation, hypertension due to, [link]
aortic dissection
chest radiographs, approach to, [link]
screening for, [link][link], [link]
syncope due to, [link]
aortic stenosis, AKI due to, [link]
AOSD (adult-onset Still’s disease), [link], [link][link]
apical pneumothoraces, [link]
apices, in chest radiographs, [link]
apixaban, for atrial fibrillation, [link]
aplastic anemia
pancytopenia due to, [link]
thrombocytopenia due to, [link]
treatment of, [link]
apnea, in dying patients, [link]
ARBs. See [link]
ARDS (acute respiratory distress syndrome), [link]
ARNI (angiotensin receptor-neprilysin inhibitor), in chronic HFrEF management, [link]
arrhythmias. See also [link]
ACS complications, [link][link]
acute dyspnea and, [link]
atrial flutter, [link], [link][link]
atrial tachycardia, [link][link], [link]
bradyarrhythmias, [link]
CHF and, [link]
sinus tachycardia, [link][link], [link], [link]
syncope from, [link]
tachyarrhythmias, [link]
narrow, irregular, [link]
narrow, regular, [link][link]
wide, irregular, [link][link]
wide, regular, [link][link]
ventricular tachycardia, [link]
arterial blood gases
in chest pain evaluation, [link]
in pulmonary embolism evaluation, [link]
sampling procedure, [link][link]
arterial catheter placement, [link][link]
arterial oxygen tension (PaO2), [link]
arteriography, in massive hemoptysis evaluation, [link]
arteriovenous malformations
GI bleeding due to, [link]
hemoptysis due to, [link]
arteritis
Takayasu’s, [link]
temporal, [link][link]
arthralgias, [link]
arthritis
in acute rheumatic fever evaluation, [link]
in AOSD, [link]
approach to diagnosis, [link][link]
history taking, [link][link]
imaging in evaluation of, [link][link]
laboratory testing of blood, [link]
laboratory testing of joint fluid, [link][link]
monoarthritis, [link][link]
oligoarthritis, [link][link]
overview of, [link]
physical examination, [link]
polyarthritis, [link][link]
arthrocentesis, [link][link]
ascending aortic dissection, [link]
ascites
approach to patient with, [link][link]
causes of, [link]
defined, [link]
ESLD and, [link]
treatment of, [link]
aseptic meningitis, [link], [link], [link]
aspergillosis
FUO due to, [link]
hemoptysis due to, [link]
aspiration, acute dyspnea due to, [link]
aspirin
acquired platelet dysfunction due to, [link]
in ACS management, [link]
in angina management, [link]
for atrial fibrillation, [link]
in ET management, [link]
in ischemic infarction management, [link]
perioperative management of, [link], [link]
in PV management, [link]
salicylate toxicity, [link]
in thrombocytosis management, [link][link]
assist control (AC), [link]
asterixis, acute liver failure and, [link]
asthma
clinical manifestations of, [link]
defined, [link]
diagnosis of, [link]
treatment of, [link]
asthma-COPD overlap syndrome (ACOS), [link]
asymmetric breath sounds, in shock evaluation, [link]
asymptomatic bacteriuria, [link]
AT (atrial tachycardia), [link][link], [link]
atenolol, in angina management, [link]
atherosclerosis
nephrotic syndrome and, [link]
risk factors for, [link]
ATN (acute tubular necrosis), [link], [link][link], [link]
atopic dermatitis, [link]
atorvastatin, [link]
atrial fibrillation
with aberrancy, [link][link]
approach to patient with, [link]
causes of, [link][link]
classification of, [link]
clinical manifestations of, [link][link]
complications of, [link]
epidemiology of, [link]
overview, [link]
pathophysiology of, [link]
thromboembolic risk reduction, therapy for, [link][link]
treatment of, [link][link]
atrial flutter
described, [link]
treatment of, [link], [link][link]
with variable block, [link]
atrial tachycardia (AT), [link][link], [link]
atrioventricular (AV) nodal blocking agents, for atrial fibrillation, [link][link], [link]
atrioventricular nodal reentrant tachycardia (AVNRT), [link][link], [link], [link]
atrioventricular reentrant tachycardia (AVRT), [link][link], [link], [link]
atropine
for bradyarrhythmias related to ACS, [link]
for cholinergic agonist toxicity, [link]
aura, [link]
autoimmune hemolytic anemia (AIHA), [link], [link]
autoimmune hepatitis, [link], [link]
autoimmune myositis, [link][link]
autoimmune parathyroid destruction, [link][link]
autoimmune thrombotic disease, [link]
autoinflammatory diseases, [link]
autologous bone marrow transplantation, in multiple myeloma management, [link]
automatism(s), [link]
autonomic failure, [link]
autonomous toxic adenomas, [link]
AV (atrioventricular) nodal blocking agents, for atrial fibrillation, [link][link], [link]
avascular necrosis
MRI in evaluation of, [link]
radionuclide bone scan in evaluation of, [link]
AVNRT (atrioventricular nodal reentrant tachycardia), [link][link], [link], [link]
AVRT (atrioventricular reentrant tachycardia), [link][link], [link], [link]
axial arthritis
MRI in evaluation of, [link]
radiographs for, [link]
axis interpretation in EKGs, [link][link]
azacitidine (Vidaza), [link]


B
Bacillus, [link]
back pain, spinal cord compression and, [link]
backward heart failure, [link]
bacteremia(s), FUO due to, [link]
bacterial endocarditis, [link], [link]
bacterial infections
exanthems due to, [link]
FUO due to, [link]
in HIV infected patients, [link]
HIV-related enterocolitis from, [link]
HIV-related meningitis due to, [link], [link]
lymphadenopathy due to, [link]
pulmonary infiltrates in HIV, differential diagnosis of, [link]
rashes from, [link]
splenomegaly due to, [link]
bacterial meningitis, acute, [link], [link], [link]
bacteriuria, asymptomatic, [link]
β‎-agonist(s)
in acute dyspnea management, [link]
hyperkalemia and, [link]
BAL (blood alcohol level), [link][link]
banana bag, [link]
Bartter’s syndrome, [link], [link]
basophilia, [link]
β‎-blockers
in ACS management, [link]
in alcohol withdrawal management, [link]
in angina management, [link][link]
anxiety management in dying patients, [link]
for atrial fibrillation, [link]
in chronic HFrEF management, [link]
in perioperative risk reduction strategies, [link]
bedsores, [link]
Behçet’s syndrome, [link][link]
benzodiazepine(s)
in alcohol withdrawal management, [link]
for anxiety in dying patients, [link]
for nausea and vomiting, [link]
for phenothiazine overdose, [link]
in stimulant overdose management, [link]
Berger’s disease, [link]
Bernard-Soulier syndrome, [link], [link]
bicarbonate, in hyperkalemia management, [link]
biliary obstruction, extrahepatic, [link]
biliary stones, acute pancreatitis due to, [link]
biomarkers, in pulmonary embolism evaluation, [link]
biopsy(ies)
bone marrow
in acute leukemia evaluation, [link]
in CML evaluation, [link]
in ET evaluation, [link]
in lymphocytosis evaluation, [link]
in MDS evaluation, [link]
in pancytopenia evaluation, [link][link]
in PMF evaluation, [link]
in PV evaluation, [link]
in thrombocytopenia evaluation, [link]
in thrombocytosis evaluation, [link]
in FUO evaluation, [link]
in Hodgkin’s lymphoma evaluation, [link]
liver
in acute liver failure evaluation, [link]
in HIV-related hepatobiliary disease evaluation, [link]
in non-Hodgkin’s lymphoma evaluation, [link]
peritoneal, in ascites evaluation, [link]
renal, in AKI evaluation, [link]
stereotactic brain, in space-occupying lesion evaluation, [link]
sural nerve, in polyneuropathy evaluation, [link]
surgical lung, in ILD evaluation, [link]
transbronchial, in ILD evaluation, [link]
bismuth subsalicylate, in acute diarrhea management, [link]
bisphosphonate(s)
in multiple myeloma management, [link]
for pain treatment in dying patients, [link]
bite(s), animal, [link], [link][link]
bladder neck obstruction, AKI due to, [link]
bladder pathology, dysuria and, [link]
blanchable erythema, [link]
blast cells
in acute leukemia evaluation, [link]
in pancytopenia evaluation, [link]
bleeding
acute GI
approach to patient with, [link][link]
causes of, [link][link]
classification of, [link]
definitions, [link]
in multiple myeloma evaluation, [link]
stress-related UGIB, [link]
variceal, management of, [link][link]
bleeding disorders
approach to patient with, [link][link]
PFA-100 in, [link][link]
platelet count in, [link]
PT/PTT in, [link][link]
clinical manifestations of, [link]
described, [link]
treatment of, [link][link]
blood alcohol level (BAL), [link][link]
blood cultures
in fever evaluation, [link]
in HIV-related enterocolitis evaluation, [link]
in infective endocarditis evaluation, [link]
in meningitis evaluation, [link]
blood pressure
hypokalemia and, [link][link]
in shock evaluation, [link]
blood smears, in FUO evaluation, [link]
blood urea nitrogen (BUN)
in DKA evaluation, [link]
in thrombocytopenia evaluation, [link]
BNI (brief negotiated interview), [link]
body fluid analysis, in fever evaluation, [link]
body temperature, normal, [link]
bone marrow biopsy
in acute leukemia evaluation, [link]
in CML evaluation, [link]
in ET evaluation, [link]
in FUO evaluation, [link]
in Hodgkin’s lymphoma evaluation, [link]
in lymphocytosis evaluation, [link]
in MDS evaluation, [link]
in pancytopenia evaluation, [link][link]
in PMF evaluation, [link]
in PV evaluation, [link]
in thrombocytopenia evaluation, [link]
in thrombocytosis evaluation, [link]
bone marrow disorders, thrombocytopenia due to, [link]
bone marrow transplantation
in ALL management, [link]
allogeneic
in AML management, [link]
in CML management, [link]
in MDS management, [link]
in PMF management, [link]
in aplastic anemia management, [link]
autologous, in multiple myeloma management, [link]
complications of, [link]
in PNH management, [link]
bone(s)
metastasis to, [link][link]
outside-in radiograph approach for, [link]
pain in, FUO and, [link]
bony lesions, in Waldenström’s macroglobulinemia evaluation, [link]
Bordetella pertussis, [link]
bradyarrhythmia(s), [link], [link]
bradycardia, [link]
brain, metastasis to, [link]
BRAT diet, [link]
bridging therapy, [link]
brief negotiated interview (BNI), [link]
bronchiectasis, massive hemoptysis and, [link]
bronchitis
chronic, [link]
massive hemoptysis and, [link]
bronchodilators
for dyspnea, [link]
in obstructive lung disease management, [link]
bronchoscopy
in FUO evaluation, [link]
in ILD evaluation, [link]
Brucella, [link]
Brudzinski’s sign, [link]
Brugada criteria, [link][link]
bubble study, in pulmonary hypertension evaluation, [link]
Budd-Chiari syndrome, [link], [link], [link]
Buerger’s disease, [link]
bullae, [link]
BUN. See [link]
bundle branch block, [link]
butterfly rash, [link][link]


C
CABG (coronary artery bypass grafting), [link]
calcium-channel blockers (CCBs)
in ACS management, [link]
in angina management, [link]
nondihydropyridine, for atrial fibrillation, [link]
calcium gluconate, intravenous, [link]
calcium pyrophosphate deposition (CPPD) disease, [link]
Campylobacter, [link]
CA-MRSA (community-acquired MRSA), [link], [link]
cancer
acquired platelet dysfunction due to, [link]
ascites due to, [link]
HIV-related meningitis due to, [link], [link]
hypercoagulable states due to, [link]
lymphadenopathy due to, [link]
massive hemoptysis and, [link]
metastatic neoplasms, [link][link]
pruritus due to, [link]
splenomegaly due to, [link]
candida esophagitis, [link]
candidiasis
FUO due to, [link]
in HIV infected patients, [link][link]
CAP (community-acquired pneumonia), [link]
capillary permeability, [link], [link]
Caprini Risk Score, [link]
CAPS (catastrophic antiphospholipid syndrome), [link]
capsule endoscopy, [link]
carboxyhemoglobinemia, polycythemia due to, [link], [link]
carcinoma of unknown primary (CUP), [link]
cardiac amyloidosis, [link]
cardiac auscultation, in shock evaluation, [link]
cardiac biomarker studies, in ACS evaluation, [link]
cardiac borders, outside-in radiograph approach for, [link]
cardiac catheterization with coronary angiography, [link]
cardiac disease, clubbing due to, [link]
cardiac echocardiography, [link]
cardiac resynchronization therapy (CRT), [link]
cardiac silhouette, [link]
cardiac tamponade
from ACS, [link]
acute dyspnea and, [link]
cardiogenic shock, [link], [link], [link], [link]
cardiomyopathies
dilated, [link]
inherited, [link]
restrictive, [link]
cardiovascular disease, Hodgkin’s lymphoma and, [link]
cardiovascular risk in non-cardiac surgery
perioperative risk reduction strategies, [link][link]
preoperative assessment of, [link][link]
cardiovascular syncope, [link], [link]
carotid Doppler ultrasound, [link]
carotid sinus massage, [link], [link]
carotid sinus syncope, [link]
CARP (Coronary Artery Revascularization Prophylaxis) Trial, [link]
catastrophic antiphospholipid syndrome (CAPS), [link]
catheter-associated urinary tract infection (CAUTI), [link]
catheterization
in AKI management, [link]
arterial placement, [link][link]
femoral central venous placement, [link][link]
peripheral intravenous placement, [link]
CAUTI (catheter-associated urinary tract infection), [link]
CCBs. See [link]
CD4 count
differential diagnoses according to, [link][link]
in FUO evaluation, [link]
in space-occupying lesion evaluation, [link]
C. difficile infection
in HIV-related enterocolitis evaluation, [link][link]
hospital-acquired complications, [link]
ceftriaxone, in meningitis management, [link]
ceiling effect, [link]
cellulitis, [link][link]
central diabetes insipidus (DI), [link]
central line-associated bloodstream infection (CLABSI), [link]
central nervous system (CNS) disorders/injury, electrocardiogram changes due to, [link]
central nervous system (CNS) prophylaxis
in ALL management, [link]
in AML management, [link]
central venous catheters (CVCs)
central line-associated bloodstream infection, [link]
venous thromboembolism, [link][link]
central vertigo, [link][link], [link]
cephalization, [link]
cerebral edema, acute liver failure and, [link]
cerebrospinal fluid (CSF) analysis
in acute leukemia evaluation, [link]
in fever evaluation, [link]
in meningitis evaluation, [link][link]
chamber enlargement, [link]
charcoal, activated, [link][link], [link], [link]
chemotherapy
for acute leukemia, [link]
for ALL, [link][link]
for AML, [link]
dysuria and, [link]
for Hodgkin’s lymphoma, [link]
for MDS, [link]
for multiple myeloma, [link][link]
for spinal cord compression, [link]
chest pain. See also [link]
from ACS, [link]
approach to patient with, [link][link]
cause of, defining, [link][link]
killer chest pains, screening for, [link][link]
MI and, [link]
outside-in approach to cause of, [link]
overview, [link]
pulmonary embolism and, [link]
chest radiographs
for abdominal pain evaluation, [link]
in acute leukemia evaluation, [link]
in fever evaluation, [link]
in Hodgkin’s lymphoma evaluation, [link]
in ILD evaluation, [link]
in massive hemoptysis evaluation, [link]
outside-in approach to, [link]
in pleural effusion evaluation, [link]
in polyneuropathy evaluation, [link]
preliminary considerations, [link]
preoperative testing, [link]
pulmonary disease evaluation in HIV-infected patients, [link]
in pulmonary embolism evaluation, [link]
in pulmonary hypertension evaluation, [link]
chest wall examination, chest pain and, [link]
CHF. See [link]
Chlamydiae, [link]
chloramphenicol, in meningitis management, [link]
cholestatic drugs, pruritus due to, [link]
cholestatic liver injury pattern, [link]
cholesterol embolization, eosinophilia due to, [link]
cholinergic agonist toxicity, [link][link]
chronic bronchitis, [link]
chronic eosinophilic leukemia, [link]
chronic glomerulonephritis, [link]
chronic hepatitis, [link], [link]
chronic hypoxemia, pulmonary hypertension and, [link]
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), [link]
chronic insufficiency, [link]
chronic liver disease, macrocytic anemia due to, [link]
chronic meningitis, [link], [link][link]
chronic myeloid leukemia (CML), [link], [link], [link][link]
chronic obstructive pulmonary disease (COPD)
clinical manifestations of, [link]
defined, [link]
diagnosis of, [link]
left axis deviation, [link]
perioperative pulmonary risks due to, [link], [link]
treatment of, [link]
chronic pancreatitis, [link]
chronic renal disease, hypercoagulable states due to, [link]
chronic thromboembolic pulmonary hypertension (CTEPH), [link]
Churg-Strauss syndrome, [link], [link]
Chvostek’s sign, [link]
chylous ascites, [link]
CIDP (chronic inflammatory demyelinating polyradiculoneuropathy), [link]
CIN (contrast-induced nephropathy), [link][link]
cirrhosis
alcoholic liver disease, [link], [link], [link]
ascites due to, [link]
primary biliary, pruritus due to, [link]
CJD (Creutzfeldt-Jacob disease), [link]
CK-myocardial band (CK-MB), in ACS evaluation, [link]
CLABSI (central line-associated bloodstream infection), [link]
clopidogrel, [link]
Clostridium, [link]
Clostridium difficile colitis, [link], [link]
clot prophylaxis, [link]
clubbing
approach to patient with, [link]
causes of, [link]
clinical manifestations of, [link]
described, [link]
treatment of, [link]
CML (chronic myeloid leukemia), [link], [link], [link][link]
CMV. See [link]
CNS (central nervous system) disorders/injury, electrocardiogram changes due to, [link]
CNS prophylaxis, [link]. See [link]
coagulation factor deficiency, [link], [link]
coagulation factor inhibitor, [link][link], [link]
coagulation tests, in acute leukemia evaluation, [link]
coagulopathy
hemoptysis and, [link]
liver failure and, [link]
cocaine
overdose of, [link]
vasculitis-like syndrome due to, [link]
cocci
gram-negative, [link]
gram-positive, [link]
coccidioidomycosis
eosinophilia due to, [link]
FUO due to, [link]
HIV infections and, [link]
Cogan’s syndrome, [link]
collagen vascular disease
ILD due to, [link]
splenomegaly due to, [link]
colonoscopy, in GI bleeding management, [link]
combination pain, in dying patients, [link]
combined ventilator modes, [link]
comfort care, [link]
common faint, [link]
communication
with family, during dying process, [link][link]
with patients, [link]
community-acquired MRSA (CA-MRSA), [link], [link]
community-acquired pneumonia (CAP), [link]
complement-mediated cell lysis, [link]
compression Doppler ultrasonography, in pulmonary embolism evaluation, [link]
computed tomography (CT)
for abdominal pain evaluation, [link]
aortic dissection, diagnosing, [link]
in arthritis evaluation, [link]
in ascites evaluation, [link]
in fever evaluation, [link]
in FUO evaluation, [link]
in HIV-related hepatobiliary disease evaluation, [link]
in massive hemoptysis evaluation, [link]
in polyneuropathy evaluation, [link]
in space-occupying lesion evaluation, [link][link]
in spinal cord compression evaluation, [link]
in UTI evaluation, [link]
computed tomography (CT) angiography
in angina evaluation, [link]
in pulmonary embolism evaluation, [link], [link]
in stroke evaluation, [link]
congenital heart disease
left axis deviation, [link]
right axis deviation, [link]
congenital storage pool diseases, [link], [link]
congenital thrombocytopenia, [link]
congestive heart failure. See [link]
conjugated bilirubin, [link]
connective tissue diseases. See [link]
consolidation therapy, in acute leukemia management, [link], [link]
constipation, in dying patients, management of, [link][link]
constrictive pericarditis, ascites due to, [link], [link]
continuous positive airway pressure (CPAP), [link]
contrast dye, AKI due to, [link]
contrast-induced nephropathy (CIN), [link][link]
Coombs test, [link]
COPD. See [link]
core biopsy
in Hodgkin’s lymphoma evaluation, [link]
in non-Hodgkin’s lymphoma evaluation, [link]
Cornell Criteria, [link]
coronary angiography
in ACS management, [link]
cardiac catheterization with, [link]
coronary artery bypass grafting (CABG), [link]
coronary artery bypass surgery, in angina management, [link][link]
coronary artery disease
antiarrhythmic therapy, [link]
clinical manifestations of, [link][link]
Coronary Artery Revascularization Prophylaxis (CARP) Trial, [link]
cor pulmonale, [link]
corticosteroid(s)
for fatigue in dying patients, [link]
perioperative management of, [link][link]
polycythemia due to, [link][link]
Corynebacterium, [link]
C. diphtheriae, [link]
C. jeikeium, [link]
cosyntropin (ACTH) stimulation test, [link]
cough, chronic, [link]
Coumadin skin necrosis, [link]
COURAGE trial, [link]
CPAP (continuous positive airway pressure), [link]
CPPD (calcium pyrophosphate deposition) disease, [link]
creatine kinase
in ACS evaluation, [link]
in AKI evaluation, [link]
creatinine
in DKA evaluation, [link]
in multiple myeloma evaluation, [link]
in thrombocytopenia evaluation, [link]
crepitus, [link]
Creutzfeldt-Jacob disease (CJD), [link]
CRT (cardiac resynchronization therapy), [link]
cryoablation ablation, for atrial fibrillation, [link]
cryoglobulinemia, [link], [link]
cryoprecipitate, in bleeding disorder management, [link]
cryptococcosis, [link]
Cryptococcus species infection, [link]
crystal arthritis, [link], [link], [link]
CSF analysis. See [link]
CT. See [link]
CT angiography. See [link]
CTEPH (chronic thromboembolic pulmonary hypertension), [link]
Cullen’s sign, [link]
culture-negative endocarditis, [link][link]
culture(s)
of ascitic fluid, [link]
blood
in fever evaluation, [link]
in HIV-related enterocolitis evaluation, [link]
in infective endocarditis evaluation, [link]
in meningitis evaluation, [link]
in fever evaluation, [link]
in FUO evaluation, [link]
CUP (carcinoma of unknown primary), [link]
Cushing’s syndrome
hypertension due to, [link]
metabolic alkalosis due to, [link]
polycythemia due to, [link][link]
cutaneous disorders, eosinophilia due to, [link]
CVCs. See [link]
cyclosporine, hyperkalemia from, [link]
cystitis
recurrent
approach to patient with, [link]
treatment of, [link][link]
uncomplicated
approach to patient with, [link]
treatment of, [link]
cytogenetic studies, in CML evaluation, [link]
cytomegalovirus (CMV) infection
acute liver failure due to, [link]
bone marrow transplantation and, [link]
CD4 count and, [link]
esophagitis due to, [link]
FUO due to, [link]
HIV-related meningitis due to, [link]
polyradiculopathy due to, [link]
cytopenias, in FUO evaluation, [link]


D
dabigatran, for atrial fibrillation, [link]
Dacogen (decitabine), [link]
DAPT (dual antiplatelet therapy), [link]
dasatinib (Sprycel), in CML management, [link]
DDAVP (desmopressin), [link]
D-dimer assay, in pulmonary embolism evaluation, [link], [link]
death
pronouncement, [link]
responding to grief, [link]
signs of approaching, [link]
death rattle, [link]
decitabine (Dacogen), [link]
decubitus ulcers, [link]
deep venous thrombosis (DVT)
anticoagulation therapy for, [link][link]
hospital-acquired complications, [link][link]
hypercoagulable state evaluation, [link]
pulmonary embolism and, [link]
dehydration, polycythemia due to, [link]
delirium, [link]
delirium tremens, [link]
dementia
described, [link]
HIV-associated, [link]
depression, in dying patients, management of, [link]
descending aortic dissection, [link]
desmopressin (DDAVP), [link]
desquamating rashes, [link]
DGI (disseminated gonococcal infection), [link]
DHS (drug hypersensitivity syndrome), [link][link]
diabetes insipidus (DI), hypernatremia and, [link]
diabetes mellitus
nephrotic syndrome due to, [link]
perioperative medication management, [link]
diabetic ketoacidosis (DKA)
anion gap acidosis due to, [link]
approach to patient with, [link]
causes of, [link]
clinical manifestations of, [link][link]
definition, [link]
treatment of, [link][link]
diagnoses, continuum of, [link]
dialysis
for acute kidney injury, [link]
in hyperkalemia management, [link]
for salicylate toxicity, [link]
diaphragm, outside-in radiograph approach for, [link]
diarrhea
acute
approach to patient with, [link][link]
classification of, [link]
defined, [link]
in hospitalized patients, common causes of, [link]
treatment of, [link]
HIV-related enterocolitis, [link]
metabolic acidosis from, [link]
DIC. See [link]
diet
in acute diarrhea management, [link]
in ESLD management, [link]
in hyperkalemia management, [link]
differential diagnosis
continuum of diagnoses, [link]
systematic approach to, [link][link]
diffuse alveolar hemorrhage, massive hemoptysis and, [link]
diffusing capacity for carbon monoxide (DLCO), [link], [link]
diffusion defects, [link]
digoxin
for atrial fibrillation, [link]
in chronic HFrEF management, [link]
dihydropyridines, in angina management, [link]
dilated cardiomyopathies, [link]
diltiazem
in angina management, [link]
for atrial fibrillation, [link]
Dilute Russell’s viper venom time (dRVVT), [link]
diphenhydramine, for phenothiazine overdose, [link]
diphtheria, [link]
diphtheroids, [link]
dipyridamole, in angina evaluation, [link]
direct hepatotoxicity, [link][link]
direct oral anticoagulants (DOACs), [link], [link]
direct thrombin inhibitors, in pulmonary embolism management, [link]
disc(s), herniated, [link], [link]
disease-modifying antirheumatic drugs (DMARDs), [link]
disorganized thinking, [link]
dispensing errors, [link]
disseminated candidal disease, in HIV infected patients, [link]
disseminated gonococcal infection (DGI), [link]
disseminated intravascular coagulation (DIC)
acquired platelet dysfunction due to, [link]
acute leukemia and, [link]
in acute leukemia evaluation, [link]
bleeding disorder management, [link]
MAHA due to, [link]
in thrombocytopenia evaluation, [link]
distal symmetric peripheral neuropathies, [link][link]
distributive shock, [link]
diuretic(s)
in acute dyspnea management, [link]
in chronic HFrEF management, [link]
for dyspnea, [link]
in hyperkalemia management, [link]
hypokalemia and, [link]
diverticulosis, [link]
Dix-Hallpike test, [link][link]
dizziness, [link]
DKA. See [link]
DLCO (diffusing capacity for carbon monoxide), [link], [link]
DMARDs (disease-modifying antirheumatic drugs), [link]
DNR or DNAR (do not resuscitate) orders, [link][link]
DOACs (direct oral anticoagulants), [link], [link]
dobutamine, in ACS management, [link]
dobutamine stress echocardiography, in angina evaluation, [link]
dofetilide, for atrial fibrillation, [link]
do not resuscitate (DNR or DNAR) orders, [link][link]
Doppler echocardiography, in pulmonary hypertension evaluation, [link]
Doppler ultrasound
carotid, in stroke evaluation, [link]
compression, in pulmonary embolism evaluation, [link]
transcranial, in stroke evaluation, [link]
double-density sign, [link]
DPAHC (durable power of attorney for health care), [link]
DRESS (drug rash with eosinophilia and systemic symptoms), [link][link]
dronabinol, for nausea and vomiting, [link]
dronedarone, for atrial fibrillation, [link][link]
drug hypersensitivity syndrome (DHS), [link][link]
drug-induced orthostasis, [link]
drug overdose(s)
general approach to, [link][link]
prevalence of, [link]
specific toxic syndromes, [link][link]
drug rash with eosinophilia and systemic symptoms (DRESS), [link][link]
drug(s). See also specific types
acquired platelet dysfunction due to, [link]
acute diarrhea due to, [link]
acute liver failure due to, [link][link]
acute pancreatitis due to, [link]
administration records, preventing errors in, [link][link]
adverse drug events, [link][link]
aplastic anemia due to, [link]
ESLD due to, [link]
exanthems due to, [link]
hypercoagulable states due to, [link]
hyperkalemia from, [link]
hypertension due to, [link]
hypothyroidism due to, [link]
ILD due to, [link]
nephrotic syndrome due to, [link]
for non-pain symptoms in dying patients, [link][link]
for pain treatment in dying patients, [link][link]
pancytopenia due to, [link]
perioperative cardiovascular risk reduction, [link][link]
perioperative medication management, [link][link]
rashes from, [link]
thrombocytopenia due to, [link], [link][link]
dRVVT (Dilute Russell’s viper venom time), [link]
dual antiplatelet therapy (DAPT), [link]
Duke Activity Status Index, [link]
duloxetine, [link]
durable power of attorney for health care (DPAHC), [link]
DVT. See [link]
dying patients
anxiety, treating, [link]
approach to, [link][link]
communication with family, [link][link]
constipation, treating, [link][link]
after death, [link]
depression, treating, [link]
dyspnea, treating, [link][link]
fatigue, treating, [link]
general discussion, [link]
goals of care discussion, [link][link]
nausea and vomiting, treating, [link]
non-pain symptoms, treatment of, [link][link]
pain management, [link][link]
signs of approaching death, [link]
dysesthesia, [link]
dysfibrinogenemia, [link]
dyslipidemia, [link]
dyspnea
acute
approach to patient with, [link]
causes of, [link]
defined, [link]
treatment of, [link]
in dying patients, treating, [link][link]
dysuria
clinical manifestations of UTI, [link]
differential diagnosis of, [link][link]


E
ecchymoses, [link]
echocardiography
in infective endocarditis evaluation, [link]
in pulmonary hypertension evaluation, [link]
for syncope, [link]
eculizumab, in PNH management, [link]
edema
ESLD and, [link]
nephritic syndrome and, [link]
edoxaban, for atrial fibrillation, [link]
EEG (electroencephalogram), in seizure disorder evaluation, [link]
EGPA (eosinophilic granulomatosis with polyangiitis), [link], [link]
EKGs. See [link]
elective surgery, [link]
electrical cardioversion
for atrial fibrillation, [link], [link], [link]
for narrow, irregular tachyarrhythmias, [link]
electrocardiograms (EKGs)
for abdominal pain evaluation, [link]
in ACS evaluation, [link][link]
in angina evaluation, [link], [link]
atrial fibrillation, [link]
atrial flutter, [link]
atrial tachycardia, [link]
AVNRT and, [link][link]
in AVRT evaluation, [link]
bradyarrhythmias, [link]
in chest pain evaluation, [link]
hyperkalemia and, [link]
hypokalemia and, [link]
in infective endocarditis follow-up, [link]
interpretation of
axis, [link][link]
classic changes in selected conditions, [link][link]
hypertrophy, [link][link]
intervals, [link][link]
overview, [link]
Q waves, [link]
rate, [link]
rhythm, [link]
ST/T wave changes, [link]
multifocal atrial tachycardia, [link]
in pulmonary embolism evaluation, [link]
in pulmonary hypertension evaluation, [link]
in shock evaluation, [link]
sinus tachycardia, [link]
for syncope, [link][link]
for toxicologic emergencies, [link]
electroencephalogram (EEG), in seizure disorder evaluation, [link]
electrolyte panel, in acute leukemia evaluation, [link]
electrolyte replacement, in DKA management, [link][link]
electrophysiologic (EP) studies, for syncope, [link]
eltrombopag, in ITP management, [link]
embolism, pulmonary. See [link]
embolus(i), infective endocarditis and, [link]
emergency situations
hypertension related, [link][link]
mechanical ventilation in, [link]
surgery, [link]
emergent surface echocardiogram, [link][link]
emetics, [link]
emphysema, [link]
empiric therapy
for fever, [link][link]
for HIV-related esophagitis, [link]
for infective endocarditis, [link][link]
for meningitis, [link], [link]
for pneumonia, [link]
empyema, [link]
encephalopathy
acute liver failure and, [link][link], [link]
HIV-related, [link][link]
endocarditis, acute, [link]
endocrine disorders, pruritus due to, [link]
end-of-life care
anxiety, treating, [link]
approach to dying patient, [link][link]
communication with family, [link][link]
constipation, treating, [link][link]
after death, [link]
depression, treating, [link]
dyspnea, treating, [link][link]
fatigue, treating, [link]
general discussion, [link]
goals of care discussion, [link][link]
nausea and vomiting, treating, [link]
non-pain symptoms, treatment of, [link][link]
pain management, [link][link]
signs of approaching death, [link]
endoscopic retrograde cholangiopancreatography (ERCP), [link]
endoscopy
in FUO evaluation, [link]
in GI bleeding evaluation, [link], [link]
in HIV-related enterocolitis evaluation, [link]
in HIV-related esophagitis evaluation, [link]
end-stage liver disease (ESLD)
AKI due to, [link]
approach to patient with, [link][link]
causes of, [link][link]
clinical manifestations of, [link]
defined, [link]
treatment of, [link][link]
Enterococcus, [link], [link]
enterocolitis, HIV-related, [link]
eosinopenia, [link]
eosinophil-associated lung diseases, [link]
eosinophilia
causes of, [link]
defined, [link]
eosinophils, overview of, [link]
eosinophilic granuloma, [link]
eosinophilic granulomatosis with polyangiitis (EGPA), [link], [link]
eosinophils, overview of, [link]
EP (electrophysiologic) studies, for syncope, [link]
epidural hematoma, [link]
epidural hemorrhage, [link]
epilepsy
defined, [link]
epidemiology of, [link]
treatment of, [link][link]
Epstein-Barr virus, [link], [link]
eptifibatide, [link]
ERCP (endoscopic retrograde-cholangiopan creatography), [link]
erosive arthritis
CT in evaluation of, [link]
MRI in evaluation of, [link]
ultrasound in evaluation of, [link]
error disclosure, [link]
erysipelas, [link]
Erysipelothrix, [link]
erythema marginatum, [link]
erythema nodosum, [link]
erythrocyte sedimentation rate (ESR), in multiple myeloma evaluation, [link]
erythromelalgia, [link], [link]
erythropoietin, in MDS management, [link]
erythropoietin-secreting tumors, polycythemia due to, [link], [link]
Escherichia coli, [link]
ESLD. See [link]
esmolol, for atrial fibrillation, [link]
esophageal varices, bleeding, [link][link]
esophagitis, HIV-related, [link][link]
ESR (erythrocyte sedimentation rate), in multiple myeloma evaluation, [link]
essential hypertension, [link][link]
essential thrombocytosis (ET), [link], [link], [link][link]
ethanol abuse, [link]
ethylene glycol intoxication, [link]
euvolemic hypoosmolar hyponatremia, [link]
evaporative cooling, in fever management, [link]
event recorders, for syncope, [link]
exanthems
described, [link][link]
types of, [link][link]
excisional biopsy
in Hodgkin’s lymphoma evaluation, [link]
in non-Hodgkin’s lymphoma evaluation, [link]
exercise-based cardiac rehabilitation, in ACS management, [link]
exercise EKG, in angina evaluation, [link]
exercise stress echocardiography, in angina evaluation, [link]
exercise treadmill testing, for syncope, [link]
expected adverse reactions, [link]
expiratory flow rate, [link]
exploratory laparotomy, in FUO evaluation, [link]
extensive lateral wall myocardial infarction, [link]
extrahepatic biliary obstruction, [link]
extrapulmonary tuberculosis, [link]
extrapyramidal dystonic effects, [link]
exudative effusions, [link], [link]


F
FAB (French-American-British) classification of MDS, [link]
factitious thyrotoxicosis, [link]
factor deficiency, coagulation, [link], [link]
factor inhibitor, coagulation, [link], [link]
factor V Leiden mutation, [link]
failure to oxygenate, [link]
failure to ventilate, [link]
fall(s), [link]
familial hypocalciuric hypercalcemia (FHH), [link]
familial Mediterranean fever, [link]
family, communication during dying process, [link][link]
Fanconi’s anemia, [link]
fatigue, in dying patients, management of, [link]
fatty liver, [link], [link]
felodipine, in angina management, [link]
femoral central venous catheter placement, [link][link]
FENa (fractional excretion of sodium), [link][link]
ferritin
in acute liver failure evaluation, [link]
AOSD in, [link]
fertility, Hodgkin’s lymphoma effects on, [link]
FEUrea (fractional excretion of urea), [link]
FEV1 (forced expiratory volume in 1 second), [link], [link], [link]
FEV1/FVC ratio, [link], [link]
fever
acute leukemia and, [link]
in AOSD, [link]
approach to patient with, [link][link]
causes of, [link]
described, [link]
infective endocarditis and, [link], [link]
from meningitis, [link]
normal body temperature, [link]
rash and
approach to patient with, [link][link]
causes of, [link][link]
described, [link]
top-to-bottom approach, [link]
treatment of, [link][link]
fever of unknown origin (FUO)
approach to patient with, [link][link]
causes of, [link][link]
defined, [link]
FHH (familial hypocalciuric hypercalcemia), [link]
fibrinolysis, in ACS management, [link][link]
first-degree AV nodal block, [link]
flecainide, for atrial fibrillation, [link]
flexible bronchoscopy, in massive hemoptysis evaluation, [link]
flow-cycled modes, [link]
flow cytometry, in lymphocytosis evaluation, [link]
fluconazole, in HIV-related esophagitis management, [link]
fluid analysis, in ascites evaluation, [link]
fluid replacement
in AKA management, [link]
in DKA management, [link][link]
fluid resuscitation, in shock management, [link]
fluoroquinolones, in cystitis management, [link]
focal lesion, [link]
focal seizures, [link]
fondaparinux, in pulmonary embolism management, [link]
forced expiratory volume in 1 second (FEV1), [link], [link], [link]
forced vital capacity, [link]
forward heart failure, [link]
fosfomycin, in cystitis management, [link]
fosphenytoin, [link]
fractional excretion of sodium (FENa), [link][link]
fractional excretion of urea (FEUrea), [link]
Francisella tularensis, [link]
FRC (functional residual capacity), [link]
free wall rupture, from ACS, [link]
French-American-British (FAB) classification of MDS, [link]
fresh-frozen plasma, in bleeding disorder management, [link]
functional capacity, determining, [link]
functional residual capacity (FRC), [link]
fungal coverage, in meningitis management, [link]
fungal endocarditis, [link]
fungal esophagitis, HIV-related, [link]
fungal infections
bone marrow transplantation and, [link]
chronic meningitis due to, [link]
FUO due to, [link]
HIV-related meningitis due to, [link], [link]
infective endocarditis, [link]
pulmonary infiltrates in HIV, differential diagnosis of, [link]
splenomegaly due to, [link]
FUO. See [link]
furosemide
in ATN management, [link]
in ESLD management, [link]


G
gabapentin, [link]
Gaisböck’s polycythemia, [link]
ganciclovir, for HIV-related viral esophagitis, [link]
gastric lavage, [link]
gastrointestinal (GI) bleeding, acute
approach to patient with, [link][link]
causes of, [link][link]
classification of, [link]
definitions, [link]
gastrointestinal (GI) disease, clubbing due to, [link]
gastrointestinal system, manifestations of HIV infections in
described, [link]
enterocolitis, [link]
esophagitis, [link][link]
hepatobiliary disease, [link][link]
Gaucher’s disease, [link]
GCA (giant cell arteritis), [link], [link][link]
G-CSF. See [link]
general errors, [link]
generalized lymphadenopathy, [link], [link]
generalized seizures, [link][link]
GI (gastrointestinal) disease, clubbing due to, [link]
giant cell arteritis (GCA), [link], [link][link]
GI bleeding, acute. See [link]
Gitelman’s syndrome, [link]
Glanzmann’s thrombasthenia, [link], [link]
Gleevec (imatinib), in CML management, [link]
glomerular hematuria, [link]
glomerulonephritis
chronic, [link]
MPGN, [link]
postinfectious, [link][link]
glucocorticoid insufficiency, [link]
GM-CSF (granulocyte-macrophage colony-stimulating factor)
ILD and, [link]
in MDS management, [link]
goals of care discussion, [link][link]
gonococcal arthritis, [link]
Goodpasture’s syndrome, [link]
Gottron’s papules, [link][link], [link][link]
GPA. See [link]
graft-versus-host disease (GVHD), [link]
gram-negative bacilli, [link]
gram-negative cocci, [link]
gram-negative rods, [link][link]
gram-negative sepsis, [link]
gram-positive cocci, [link]
gram-positive rods, [link][link]
Gram stain with culture, in pleural effusion evaluation, [link]
granulocyte colony-stimulating factor (G-CSF)
in MDS management, [link]
in pancytopenia management, [link]
granulocyte-macrophage colony-stimulating factor (GM-CSF)
ILD and, [link]
in MDS management, [link]
granulomatosis with polyangiitis (GPA)
ILD due to, [link]
nephritic syndrome due to, [link]
vasculitis due to, [link]
granulomatous inflammation, [link]
Grey Turner’s sign, [link]
grief, responding to, [link]
growth factors, in MDS management, [link]
Guillain-Barré syndrome, [link][link]
Gupta risk index, [link]
gut decontamination, [link][link]
GVHD (graft-versus-host disease), [link]


H
H2-receptor antagonists, [link]
HACEK group organisms, [link]
Haemophilus influenzae, [link], [link], [link]
hallucinations, alcohol withdrawal, [link]
haloperidol, for nausea and vomiting, [link]
Hampton’s hump, [link]
HAP (hospital-acquired pneumonia), [link], [link], [link]
Hashimoto’s disease, [link]
HCAP (health care-associated pneumonia), [link], [link]
headaches
in FUO evaluation, [link]
from meningitis, [link]
head impulse test (HIT), [link]
health care-associated pneumonia (HCAP), [link], [link]
health literacy, [link]
heart, outside-in radiograph of, [link]
heart failure (HF)
acute, [link][link]
acute dyspnea and, [link]
approach to patient with, [link]
arrhythmias, [link]
classification schemes, [link][link]
clinical manifestations, [link]
defined, [link]
forward versus backward, [link]
HFmrEF, [link], [link]
HFrEF, [link], [link][link]
incidence, [link]
infective endocarditis complications, [link]
lift- versus right-sided, [link][link]
mortality rates, [link]
radiograph approach for, [link]
right-sided, ascites due to, [link], [link]
treatment of, [link][link]
heart failure with midrange ejection fraction (HFmrEF), [link], [link]
heart failure with preserved ejection fraction (HFpEF), [link], [link], [link]
heart failure with reduced ejection fraction (HFrEF), [link], [link][link]
heart transplantation, [link]
heated high-flow nasal cannula, in acute dyspnea management, [link]
heavy metals, nephrotic syndrome due to, [link]
heliotrope rash, [link][link], [link][link]
heliox, for obstructive lung disease, [link]
HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome, [link]
helminthic infections, eosinophilia due to, [link]
hemarthrosis, arthritis due to, [link]
hematemesis, [link]
hematochezia, [link]
hematogenous seeding, infective endocarditis and, [link]
hematologic disorders, pulmonary hypertension due to, [link]
hematuria, in FUO evaluation, [link]
hemochromatosis, [link]
hemodynamic status, in ACS evaluation, [link][link]
Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome, [link]
hemolytic anemia, [link]
hemolytic uremic syndrome (HUS), [link]
hemoptysis
approach to patient with, [link]
causes of, [link]
defined, [link]
in FUO evaluation, [link]
massive, [link]
nonmassive, [link]
hemorrhage
acute liver failure complications, [link]
epidural, [link]
liver failure complications, [link]
stroke due to, [link][link], [link][link]
hemorrhagic fevers, [link]
hemorrhagic transformation, stroke due to, [link]
Henoch-Schönlein purpura, [link]
heparin
in hypercoagulable state management, [link]
hyperkalemia from, [link]
in pulmonary embolism management, [link]
heparin-induced thrombocytopenia (HIT), [link][link]
heparin-induced thrombocytopenia and thrombosis (HITT), [link], [link]
hepatic encephalopathy, [link]
hepatic parenchymal disease, HIV-related, [link]
hepatic vein obstruction, acute liver failure due to, [link]
hepatic venoocclusive disease, [link]
hepatitis
acute, [link]
acute liver failure due to, [link], [link]
alcoholic, [link][link]
arthritis due to, [link]
autoimmune, [link], [link]
autoimmune diseases triggered by, [link]
chronic, [link], [link]
ESLD due to, [link]
nephritic syndrome due to, [link]
hepatobiliary disease, HIV-related, [link][link]
hepatocellular liver injury pattern, [link][link]
hepatomegaly, in Waldenström’s macroglobulinemia evaluation, [link]
hepatopulmonary syndrome, [link]
hepatorenal syndrome, [link][link], [link]
hereditary clubbing, [link]
herniated disc(s), [link], [link]
heroin, nephrotic syndrome due to, [link]
herpes virus infections
acute liver failure due to, [link]
bone marrow transplantation and, [link]
esophagitis due to, [link]
in HIV infected patients, [link]
HIV-related meningitis due to, [link]
HF. See [link]
HFmrEF (heart failure with midrange ejection fraction), [link], [link]
HFpEF (heart failure with preserved ejection fraction), [link], [link], [link]
HFrEF (heart failure with reduced ejection fraction), [link], [link][link]
hiccoughs
causes of, [link]
defined, [link]
treatment of, [link]
high bicarbonate syndromes, [link]
high-resolution computed tomography (HRCT), in ILD evaluation, [link]
hip fractures, [link]
histoplasmosis, [link], [link]
HIT (head impulse test), [link]
HIT (heparin-induced thrombocytopenia), [link][link]
HITT (heparin-induced thrombocytopenia and thrombosis), [link], [link]
HIV infection
CD4 counts, differential diagnoses according to, [link][link]
described, [link]
eosinophilia due to, [link]
FUO due to, [link], [link]
gastrointestinal manifestations of
described, [link]
enterocolitis, [link]
esophagitis, [link][link]
hepatobiliary disease, [link][link]
hepatic parenchymal disease, [link]
lymphadenopathy due to, [link]
neurologic manifestations of
described, [link]
encephalopathy, [link][link]
meningitis, [link][link]
myelopathy, [link]
peripheral neuropathy, [link][link]
space-occupying lesions, [link][link]
obstructive biliary tract disease, [link]
PCP and, [link][link]
pruritus due to, [link]
pulmonary infiltrates in, [link]
HIV test, [link]
Hodgkin’s lymphoma (HL), [link][link], [link]
Holter monitors, for syncope, [link]
hospice, [link]
hospital-acquired complications
ADE, [link][link]
catheter-associated UTI, [link]
C. difficile infection, [link]
CIN, [link][link]
CLABSI, [link]
falls, [link]
general errors, [link]
overview, [link]
pressure injury to skin, [link]
stress-related UGIB, [link]
VAP, [link]
VTE, [link][link]
hospital-acquired pneumonia (HAP), [link], [link], [link]
Hospital Compare website, [link]
hospitalization
acute diarrhea, common causes of, [link]
alcohol use and, [link]
pneumonia criteria for admission, [link]
Howell-Jolly bodies, [link]
HRCT (high-resolution computed tomography), in ILD evaluation, [link]
HUS (hemolytic uremic syndrome), [link]
hydration, in polycythemia management, [link]
hydrochlorothiazide, hypercalcemia due to, [link]
hydroxyurea
in CML management, [link]
in ET management, [link]
in PMF management, [link]
in PV management, [link]
in thrombocytosis management, [link]
hyperaldosteronism, primary, [link]
hypercalcemia
causes of, [link][link]
clinical manifestations of, [link]
definition, [link]
EKGs and, [link]
hypertension due to, [link]
in multiple myeloma evaluation, [link]
treatment of, [link]
in Waldenström’s macroglobulinemia evaluation, [link]
hypercapnic respiratory failure, [link]
hypercoagulable states
approach to patient with, [link][link]
causes of, [link][link]
clinical manifestations of, [link]
defined, [link]
pathogenesis, [link]
treatment of, [link][link]
hypereosinophilic syndrome, eosinophilia due to, [link]
hyperesthesia, [link]
hyperglycemia, from steroid administration, [link]
hyperhomocysteinemia, [link]
hyperimmunoglobulin G4 (hyper-IgG4) disease, [link], [link]
hyperkalemia
acute dialysis in management of, [link]
approach to patient with, [link]
causes of, [link][link]
clinical manifestations of, [link][link]
defined, [link]
described, [link]
EKG interpretation, [link], [link]
potassium excretion, decreased, [link][link]
with transcellular redistribution, [link]
treatment of, [link][link]
hyperkalemic periodic paralysis, [link]
hyperlipidemia, acute pancreatitis due to, [link]
hypernatremia
approach to patient with, [link][link]
clinical manifestations of, [link]
defined, [link]
described, [link]
treatment of, [link]
hyperosmolar hyponatremia, [link]
hyperparathyroidism, primary, [link]
hyperpigmentation, [link]
hyperproliferative normocytic anemia, [link][link]
hyperreninemic states, [link]
hypersensitivity pneumonitis, [link]
hypersplenism
pancytopenia due to, [link]
splenomegaly and, [link]
thrombocytopenia due to, [link]
hypertension
defined, [link]
emergencies, [link][link]
essential, [link][link]
nephritic syndrome and, [link]
secondary, [link][link]
urgencies, [link]
hypertensive encephalopathy, [link]
hyperthermia, [link]
hyperthyroidism, [link], [link]
hypertonic hyponatremia, [link]
hypertrophic osteoarthropathy, [link]
hypertrophy interpretation in EKGs, [link][link]
hyperviscosity
polycythemia and, [link]
in PV evaluation, [link]
in Waldenström’s macroglobulinemia evaluation, [link]
hypervolemic hypoosmolar hyponatremia, [link]
hypesthesia, [link]
hypoaldosteronism, [link]
hypocalcemia
causes of, [link][link]
clinical manifestations of, [link]
definition, [link]
described, [link]
EKGs interpretation, [link]
treatment of, [link]
hypoglycemia, [link], [link]
hypokalemia
acute liver failure and, [link], [link]
causes of, [link][link]
clinical manifestations of, [link]
defined, [link]
EKG interpretation, [link]
plasma potassium, maintenance of, [link]
potassium depletion and, [link][link]
with transcellular redistribution, [link]
treatment of, [link]
hypokalemic periodic paralysis, [link]
hypomagnesemia, [link]
hyponatremia
acute liver failure and, [link], [link]
antidiuretic hormone, action of, [link]
approach to patient with, [link][link]
clinical manifestations of, [link]
defined, [link]
in DKA evaluation, [link]
hyperosmolar, [link]
hypoosmolar, [link]
isoosmolar, [link]
SIADH, [link]
hypoosmolar hyponatremia, [link]
hypoparathyroidism, hypocalcemia due to, [link][link]
hypophosphatemia, acute liver failure and, [link], [link]
hypopituitarism, [link]
hypoproliferative normocytic anemia, [link][link]
hyporeninemic states, [link]
hypotension
in DKA evaluation, [link]
in hypocalcemia evaluation, [link]
hypothermia, in DKA evaluation, [link]
hypothyroidism
ascites due to, [link]
described, [link][link]
electrocardiogram changes, [link]
macrocytic anemia due to, [link]
hypoventilation, [link]
hypovolemia
nephrotic syndrome and, [link]
shock due to, [link]
syncope and, [link]
hypovolemic hypoosmolar hyponatremia, [link]
hypoxemia
clinical values, [link]
mechanisms of, [link]
in polycythemia evaluation, [link], [link]
pulmonary hypertension and, [link]
hypoxemic respiratory failure, [link]


I
IABP (intra-aortic balloon pump), in ACS management, [link]
ibuprofen, in fever management, [link]
ICD. See [link]
idiopathic aortic vasculitis, [link]
idiopathic interstitial pneumonia (IIP), [link]
idiopathic pulmonary fibrosis (IPF), [link]
idiosyncratic hepatotoxicity, [link]
IE. See [link]
If-channel inhibitor (ivabradine), in chronic HFrEF management, [link][link]
IFN-α‎. See [link]
IgA (immunoglobulin A) nephropathy, [link]
IIP (idiopathic interstitial pneumonia), [link]
ILD. See [link]
imatinib (Gleevec), in CML management, [link]
immobilization, hypercalcemia due to, [link]
immune complex disease, [link]
immune disorders, aplastic anemia due to, [link]
immune-mediated destruction, pancytopenia due to, [link]
immune thrombocytopenic purpura (ITP), [link], [link][link]
immunoelectrophoresis, in multiple myeloma evaluation, [link]
immunoglobulin A (IgA) nephropathy, [link]
immunologic disorders, eosinophilia due to, [link]
immunosuppressive agents
in aplastic anemia management, [link]
in ITP management, [link][link]
implantable cardiac defibrillator (ICD)
for CHF, [link]
after MI, [link]
for tachyarrhythmias related to ACS, [link]
for VT, [link]
implantable loop records, for syncope, [link]
incomplete bundle branch block, [link]
infection(s). See also [link]; [link]; [link]; [link]
acute diarrhea due to, [link]
acute liver failure and, [link], [link]
acute pancreatitis due to, [link]
aplastic anemia due to, [link]
arthritis due to, [link], [link]
catheter-associated urinary tract infection, [link]
C. difficile, [link]
central line-associated bloodstream infection, [link]
eosinophilia due to, [link]
ESLD due to, [link]
exanthems due to, [link]
HIV-associated myelopathy due to, [link]
hypocalcemia due to, [link]
liver failure complications, [link]
lymphadenopathy due to, [link], [link]
in multiple myeloma evaluation, [link]
nephrotic syndrome and, [link], [link]
pancytopenia due to, [link], [link]
pruritus due to, [link]
skin and soft tissue
animal bites, [link][link]
cellulitis, [link][link]
described, [link]
pyomyositis, [link]
spinal cord compression due to, [link], [link]
splenomegaly due to, [link]
thrombocytopenia due to, [link]
travel-related, [link]
infectious colitis, [link]
infective endocarditis (IE)
approach to patient with, [link]
causes of, [link][link]
clinical manifestations of, [link]
complications of, [link]
described, [link]
follow-up on, [link]
treatment of, [link][link]
inferior vena cava (IVC) filters
in hypercoagulable state management, [link]
in pulmonary embolism management, [link]
inferior vena cava obstruction, acute liver failure due to, [link]
inferior wall myocardial infarction, [link], [link]
inflammation, acute diarrhea due to, [link]
inflammatory arthritis
MRI in evaluation of, [link]
radionuclide bone scan in evaluation of, [link]
ultrasound in evaluation of, [link]
inflammatory bowel disease, [link]
inflammatory demyelinating polyneuropathy, [link]
inflammatory retiform purpura, [link]
influenza virus, [link]
informed consent for procedures, [link]
inherited cardiomyopathies, [link]
inherited clotting disorders, hypercoagulable states due to, [link][link]
inherited platelet dysfunction, [link]
initiation phase of ventilatory support, [link], [link]
inotropic agents, in ACS management, [link], [link]
INR (international normalization ratio), [link]
inspiration, in chest radiographs, [link]
inspired oxygen tension, [link]
insulin
in DKA management, [link]
in hyperkalemia management, [link], [link]
interferon-α‎ (IFN-α‎)
for CML, [link]
for ET, [link]
for PMF, [link]
international normalization ratio (INR), [link]
International Staging System, [link]
interstitial cystitis, [link]
interstitial infiltrates, [link]
interstitial lung disease (ILD)
approach to patient with, [link]
causes of, [link]
classification of, [link]
common features, [link]
interstitial nephritis, acute, [link], [link]
interval interpretation in EKGs, [link][link]
interventricular conduction delay, [link]
intra-abdominal infections, FUO due to, [link]
intra-aortic balloon pump (IABP), in ACS management, [link]
intracerebral hemorrhage, [link]
intraparenchymal hemorrhage, [link][link]
intravenous immunoglobulin (IVIG)
in ITP management, [link]
in peripheral neuropathy management, [link]
intravenous magnesium, in obstructive lung disease management, [link]
intravenous proton pump inhibitors, in GI bleeding management, [link]
intrinsic renal disease, hypertension due to, [link]
iodine-induced thyrotoxicosis, [link]
IPF (idiopathic pulmonary fibrosis), [link]
iron deficiency anemia, [link], [link], [link], [link]
irregular tachyarrhythmias
narrow, [link]
differential diagnosis, [link]
treatment of, [link]
wide, [link][link]
differential diagnosis, [link][link]
treatment of, [link]
ischemia(s)
gastrointestinal bleeding due to, [link]
myocardial, [link], [link][link]
ischemic disorders, [link]
ischemic infarction, [link], [link], [link][link]
isolated atrial fibrillation, [link]
isolated central nervous system vasculitis, [link]
isoniazid overdose, [link]
isoosmolar hyponatremia, [link]
isotonic hyponatremia, [link]
ITP (immune thrombocytopenic purpura), [link], [link][link]
ivabradine, in chronic HFrEF management, [link][link]
IVC filters. See [link]
IVIG (intravenous immunoglobulin)
in ITP management, [link]
in peripheral neuropathy management, [link]


J
JAK2 mutation assessment, [link], [link], [link]
JAK inhibitors, in PMF management, [link]
Janeway lesions, [link]
Jod-Basedow disease, [link]
joint effusions, ultrasound in evaluation of, [link]
joint fluid, laboratory testing of, [link][link]
Jones criteria, [link][link]
jugular venous pressure, [link]


K
Kaposi’s sarcoma, [link]
Kawasaki disease, [link]
Kayexalate, in hyperkalemia management, [link][link]
Kernig’s sign, [link]
ketoacidosis
alcoholic, [link], [link][link]
diabetic, [link], [link][link]
ketoconazole, in spinal cord compression management, [link]
kidney biopsy, [link]
kidney disease
chronic, hypercoagulable states due to, [link]
intrinsic, hypertension due to, [link]
metabolic acidosis and, [link]
kidney failure
acute liver failure complications, [link][link]
hypocalcemia due to, [link]
kidney injury, acute
approach to patient with, [link][link]
causes of, [link][link]
clinical manifestations of, [link]
defined, [link]
epidemiology of, [link]
treatment of, [link][link]
kidney transplantation, polycythemia due to, [link]
Klebsiella, [link]


L
laboratory testing
of blood, [link]
of joint fluid, [link][link]
in systemic autoimmune disease evaluation, [link][link]
lactate dehydrogenase (LDH)
in liver injury evaluation, [link]
in thrombocytopenia evaluation, [link]
lactic acidosis, [link]
LAD (left axis deviation), [link][link]
Laënnec’s cirrhosis, [link], [link], [link]
LAM (lymphangioleiomyomatosis), [link]
laparoscopy, in ascites evaluation, [link]
laparotomy, exploratory, in FUO evaluation, [link]
large-artery vasculitis, [link][link]
lateral view, [link]
lateral wall accessory pathway, [link]
LBBB (left bundle branch block), [link]
LDH. See [link]
lead reversal, [link]
left anterior fascicular block, [link]
left atrial abnormality, [link]
left axis deviation (LAD), [link][link]
left bundle branch block (LBBB), [link]
left posterior fascicular block, [link]
left-sided heart failure, [link]
left ventricular aneurysm, [link]
left ventricular assist devices, in ACS management, [link]
left ventricular hypertrophy (LVH), [link]
Legionella, [link]
leptospirosis, FUO due to, [link]
lesions
bony, in Waldenström’s macroglobulinemia evaluation, [link]
Janeway, [link]
lytic bone, in multiple myeloma evaluation, [link]
ocular, in systemic autoimmune diseases, [link]
oral, in systemic autoimmune diseases, [link]
skin, in systemic autoimmune diseases, [link]
space-occupying, HIV-related, [link][link]
leukapheresis, in CML management, [link]
leukemia
acute
approach to patient with, [link][link]
classification of, [link][link]
clinical manifestations of, [link][link]
complications associated with, [link][link]
described, [link]
epidemiology of, [link]
MDS and, [link]
risk factors for, [link]
treatment of, [link][link]
chronic eosinophilic, [link]
leukemoid reaction, [link]
leukocytosis
basophilia, [link]
definitions, [link]
described, [link]
lymphocytosis, [link]
monocytosis, [link]
neutrophilia, [link]
leukoerythroblastic smear, in pancytopenia evaluation, [link]
leukoerythroblastosis, [link], [link]
leukostasis, acute leukemia and, [link], [link]
levothyroxine, [link]
liberation phase of ventilatory support, [link], [link]
lidocaine, for VT, [link], [link]
life support, [link]
lightheadedness, [link]
Light’s criteria, [link]
likelihood ratio, [link][link]
lingular infiltrate, [link]
Listeria monocytogenes, [link], [link]
livedo reticularis, [link]
liver
core functions of, [link]
metastasis to, [link][link]
liver biopsy
in acute liver failure evaluation, [link]
in FUO evaluation, [link]
in HIV-related hepatobiliary disease evaluation, [link]
liver disease, chronic, macrocytic anemia due to, [link]
liver failure
approach to patient with, [link][link]
causes of, [link][link]
clinical manifestations of, [link][link]
definitions, [link]
treatment of, [link][link]
liver tests
abnormalities of, [link]
in bleeding disorder evaluation, [link]
described, [link]
in fever evaluation, [link]
general approach to, [link][link]
liver transplantation, [link]
living will, [link]
LMWH. See [link]
localized lymphadenopathy, [link]
Löfgren’s syndrome, [link]
lone atrial fibrillation, [link]
long-acting nitrates, [link]
long-standing persistent atrial fibrillation, [link]
loop diuretics, [link]
loop recorders, for syncope, [link]
lorazepam, [link][link]
low back pain, in infective endocarditis, [link]
low bicarbonate syndromes, [link]
lower extremity testing, noninvasive, in pulmonary embolism evaluation, [link]
lower GI tract bleeding, [link]
low inspired oxygen tension, [link]
low-molecular-weight heparin (LMWH)
in hypercoagulable state management, [link]
in pulmonary embolism management, [link]
lumbar puncture
in meningitis evaluation, [link][link]
procedure for, [link][link]
in stroke evaluation, [link]
lung auscultation, [link]
lung disease(s)
obstructive versus restrictive, [link]
pulmonary hypertension and, [link]
lung expansion maneuvers, [link]
lung(s)
in chest pain evaluation, [link]
examination of, shock and, [link]
metastasis to, [link][link]
outside-in radiograph approach for, [link]
perioperative pulmonary risks, [link][link]
pulmonary function tests, [link]
LVH (left ventricular hypertrophy), [link]
Lyme disease
FUO due to, [link]
rashes from, [link]
lymphadenopathy
approach to patient with, [link][link]
in chest radiographs, [link]
defined, [link]
in FUO evaluation, [link]
treatment of, [link]
lymphangioleiomyomatosis (LAM), [link]
lymphatic obstruction, ascites due to, [link], [link]
lymphocytic pleocytosis, [link], [link][link]
lymphocytosis, [link]
lymphoma(s)
classification of, [link]
defined, [link]
in HIV infected patients, [link]
Hodgkin’s, [link][link]
lymphadenopathy due to, [link], [link]
MALT, [link]
non-Hodgkin’s, [link][link]
primary CNS, [link]
lymphoproliferative disease, Sjögren’s syndrome and, [link]